These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3489521)
21. Inhibition of colony formation by macrophage committed stem cells during acute inflammation by purified human C-reactive protein (CRP). Mortensen RF Exp Hematol; 1983 Sep; 11(8):730-7. PubMed ID: 6313415 [TBL] [Abstract][Full Text] [Related]
22. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line. Meltzer MS; Benjamin WR; Farrar JJ J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943 [TBL] [Abstract][Full Text] [Related]
23. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection. James SL; Skamene E; Meltzer MS J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937 [TBL] [Abstract][Full Text] [Related]
24. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages. Poste G; Kirsh R Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267 [TBL] [Abstract][Full Text] [Related]
25. Binding of calmodulin to the microfilament network correlates with induction of a macrophage tumoricidal response. Mecham JO; Soong MM; Cain CA; Koehm S; Goff J; Tompkins WA J Immunol; 1985 May; 134(5):3516-23. PubMed ID: 3884713 [TBL] [Abstract][Full Text] [Related]
26. In vitro activation of tumoricidal properties of rat peritoneal macrophages using lipopolysaccharide. Kalafut F; Kusenda J; Klobusická M; Novotná L Neoplasma; 1990; 37(4):405-14. PubMed ID: 2234202 [TBL] [Abstract][Full Text] [Related]
27. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage. Varesio L J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571 [TBL] [Abstract][Full Text] [Related]
28. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor. Howard AD; Erickson KL Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340 [TBL] [Abstract][Full Text] [Related]
29. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens. James SL; Lazdins JK; Hieny S; Natovitz P J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456 [TBL] [Abstract][Full Text] [Related]
30. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains. Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895 [TBL] [Abstract][Full Text] [Related]
31. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. Boraschi D; Meltzer MS J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562 [TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharide-mediated macrophage activation: the role of calcium in the generation of tumoricidal activity. Drysdale BE; Yapundich RA; Shin ML; Shin HS J Immunol; 1987 Feb; 138(3):951-6. PubMed ID: 3100622 [TBL] [Abstract][Full Text] [Related]
33. Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine. Le PT; Muller MT; Mortensen RF J Immunol; 1982 Aug; 129(2):665-72. PubMed ID: 6806378 [TBL] [Abstract][Full Text] [Related]
34. Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study. Gautam S; Deodhar S J Biol Response Mod; 1989 Oct; 8(5):560-9. PubMed ID: 2795096 [TBL] [Abstract][Full Text] [Related]
35. Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma. Gusella GL; Musso T; Rottschafer SE; Pulkki K; Varesio L J Immunol; 1995 Jan; 154(1):345-54. PubMed ID: 7995954 [TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. Han SB; Yoon YD; Ahn HJ; Lee HS; Lee CW; Yoon WK; Park SK; Kim HM Int Immunopharmacol; 2003 Sep; 3(9):1301-12. PubMed ID: 12890428 [TBL] [Abstract][Full Text] [Related]
37. Modulation of macrophage Ia-expression by lipopolysaccharide. I. Induction of Ia expression in vivo. Ziegler HK; Staffileno LK; Wentworth P J Immunol; 1984 Oct; 133(4):1825-35. PubMed ID: 6332135 [TBL] [Abstract][Full Text] [Related]
38. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS. Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842 [TBL] [Abstract][Full Text] [Related]
39. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages. Zlotnik A; Fischer M; Roehm N; Zipori D J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588 [TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing. Zhang L; Zhu H; Lun Y; Yan D; Yu L; Du B; Zhu X Cell Mol Immunol; 2007 Oct; 4(5):359-67. PubMed ID: 17976316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]